Feed aggregator

Outsize benefit seen in trial of drug for kidney disease

World Pharma News - Mon, 12/18/2023 - 11:00
In a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced albuminuria - albumin in urine, a sign of kidney damage - for 50% of participants. When the experimental drug was paired with a standard-care medication, 70% of participants reportedly experienced a significant reduction in albuminuria.

Pfizer declares first-quarter 2024 dividend

World Pharma News - Fri, 12/15/2023 - 11:00
Pfizer Inc. (NYSE: PFE) announced that its board of directors declared an increase in the quarterly cash dividend on the company's common stock to $0.42 for the first-quarter 2024 dividend, payable March 1, 2024, to holders of the Common Stock of record at the close of business on January 26, 2024.

EMA Committee Votes Against Renewing Marketing Authorization for GSK’s Blenrep

Biospace news - Fri, 12/15/2023 - 02:00
EMA Committee Votes Against Renewing Marketing Authorization for GSK’s Blenrep 12/15/2023

MindMed Posts Positive Phase II Results for LSD-Based Treatment for Anxiety

Biospace news - Fri, 12/15/2023 - 02:00
MindMed Posts Positive Phase II Results for LSD-Based Treatment for Anxiety 12/15/2023

Biden, Big Pharma Increasingly at Loggerheads in Run-Up to 2024 Election

Biospace news - Fri, 12/15/2023 - 02:00
Biden, Big Pharma Increasingly at Loggerheads in Run-Up to 2024 Election 12/15/2023

Vertex-CRISPR’s Casgevy Gets Positive EMA Panel Opinion, Approval Decision in Q1 2024

Biospace news - Fri, 12/15/2023 - 02:00
Vertex-CRISPR’s Casgevy Gets Positive EMA Panel Opinion, Approval Decision in Q1 2024 12/15/2023

Pfizer Inks Potential $1B ADC Deal with Nona, Closes Seagen Acquisition

Biospace news - Fri, 12/15/2023 - 02:00
Pfizer Inks Potential $1B ADC Deal with Nona, Closes Seagen Acquisition 12/15/2023

Bluebird Bio Secures Deal with Large Commercial Payer for Lyfgenia Amid Price Concerns

Biospace news - Fri, 12/15/2023 - 02:00
Bluebird Bio Secures Deal with Large Commercial Payer for Lyfgenia Amid Price Concerns 12/15/2023

FDA Puts Clinical Hold on Three CARsgen Therapeutics CAR-T Candidates

Biospace news - Fri, 12/15/2023 - 02:00
FDA Puts Clinical Hold on Three CARsgen Therapeutics CAR-T Candidates 12/15/2023

FDA Approves Merck’s Welireg for Treating Renal Cell Carcinoma

Biospace news - Fri, 12/15/2023 - 02:00
FDA Approves Merck’s Welireg for Treating Renal Cell Carcinoma 12/15/2023

Sanofi, AstraZeneca Promise 230K More Doses of RSV Infant Shots for US

Biospace news - Fri, 12/15/2023 - 02:00
Sanofi, AstraZeneca Promise 230K More Doses of RSV Infant Shots for US 12/15/2023

FDA Approves First Oral High-Risk Neuroblastoma Maintenance Therapy

Biospace news - Fri, 12/15/2023 - 02:00
FDA Approves First Oral High-Risk Neuroblastoma Maintenance Therapy 12/15/2023

How Kyowa Kirin is Giving Employees a Voice in the Company's Future

Biospace news - Fri, 12/15/2023 - 02:00
How Kyowa Kirin is Giving Employees a Voice in the Company's Future 12/15/2023

FDA grants Priority Review to Amgen's tarlatamab application for advanced small cell lung cancer

World Pharma News - Thu, 12/14/2023 - 11:00
Amgen (NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the Company's Biologics License Application (BLA) for tarlatamab.

Tarlatamab is a potential first-in-class, investigational delta-like ligand 3 (DLL3) targeting Bispecific T-cell Engager (BiTE®) therapy for the treatment of adult patients with advanced small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.

White House Hits Pharma Again, Requires Rebates Over Drug ‘Price Gouging’

Biospace news - Thu, 12/14/2023 - 02:00
White House Hits Pharma Again, Requires Rebates Over Drug ‘Price Gouging’ 12/14/2023

Moderna, Merck Cancer Vaccine-Keytruda Combo Gets Win at Three-Year Mark

Biospace news - Thu, 12/14/2023 - 02:00
Moderna, Merck Cancer Vaccine-Keytruda Combo Gets Win at Three-Year Mark 12/14/2023

Pharma, Life Sciences Sector to See Healthy M&A Activity in 2024: PwC

Biospace news - Thu, 12/14/2023 - 02:00
Pharma, Life Sciences Sector to See Healthy M&A Activity in 2024: PwC 12/14/2023

How to Cope with Layoffs and Other Career Setbacks

Biospace news - Thu, 12/14/2023 - 02:00
How to Cope with Layoffs and Other Career Setbacks 12/14/2023

How to Tailor a Resume to a Job Opening

Biospace news - Thu, 12/14/2023 - 02:00
How to Tailor a Resume to a Job Opening 12/14/2023

What VCs really think of the market right now with MPM Capital, Endeavor and Two Bear Capital

Biospace news - Thu, 12/14/2023 - 02:00
What VCs really think of the market right now with MPM Capital, Endeavor and Two Bear Capital 12/14/2023